Bath & Body Works Announces Appointment of Thomas J. Kuhn 6-03-2023, 19:34

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000) 21-09-2024, 15:10

Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year 3-06-2024, 04:07